THNR
Amplify Weight Loss Drug & Treatment ETF
THNR
THNR
4 hedge funds and large institutions have $1.39M invested in Amplify Weight Loss Drug & Treatment ETF in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GS
GTS Securities
New York
|
+$183K |
| 2 |
Jane Street
New York
|
+$26.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.27K |
Top Sellers
| 1 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$25.8K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GS
1
GTS Securities
New York
| $719K | +$183K | +8,506 | +34% |
|
|
2
Jane Street
New York
| $536K | +$26.2K | +1,215 | +5% |
|
|
HI
3
Harbour Investments
Madison,
Wisconsin
| $123K | -$25.8K | -1,200 | -17% |
|
|
4
UBS Group
Zurich,
Switzerland
| $12.9K | +$3.27K | +152 | +34% |
|